perillyl alcohol has been researched along with Animal Mammary Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ariazi, EA; Ellis, MJ; Gould, MN; Haag, JD; Satomi, Y; Sattler, CA; Shi, W | 1 |
| Gould, MN; Shi, W | 1 |
2 other study(ies) available for perillyl alcohol and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Activation of the transforming growth factor beta signaling pathway and induction of cytostasis and apoptosis in mammary carcinomas treated with the anticancer agent perillyl alcohol.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Female; Mammary Neoplasms, Animal; Monoterpenes; Rats; Rats, Wistar; RNA, Neoplasm; Signal Transduction; Terpenes; Transforming Growth Factor beta | 1999 |
Induction of cytostasis in mammary carcinoma cells treated with the anticancer agent perillyl alcohol.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Division; Clinical Trials, Phase I as Topic; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Dose-Response Relationship, Drug; Flow Cytometry; G1 Phase; G2 Phase; Mammary Neoplasms, Animal; Mice; Mitosis; Monoterpenes; Phosphorylation; Retinoblastoma Protein; Terpenes; Time Factors; Tumor Cells, Cultured | 2002 |